Evidence map›Paper›PMID 39598000›Full record

ReviewJournal of clinical medicine2024

Myval Transcatheter Heart Valve: The Future of Transcatheter Valve Replacement and Significance in Current Timeline.

Teoman Kilic, Senol Coskun, Didar Mirzamidinov, Irem Yilmaz, Sadan Yavuz, Tayfun Sahin

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta-Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Pooled it
  3. Review
  4. Article
  5. Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Review
  6. Observational
  7. Transcatheter Aortic Valve Replacement for Aortic Insufficiency.Interventional cardiology (London, England) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Teoman KilicStructural Heart Interventions Unit, Department of Cardiology, Kocaeli University School of Medicine, Kocaeli 41380, Turkey.
Senol CoskunFaculty of Health Sciences, Kocaeli Health and Technology University, Kocaeli 41275, Turkey.
Didar MirzamidinovStructural Heart Interventions Unit, Department of Cardiology, Kocaeli University School of Medicine, Kocaeli 41380, Turkey.
Irem YilmazStructural Heart Interventions Unit, Department of Cardiology, Kocaeli University School of Medicine, Kocaeli 41380, Turkey.
Sadan YavuzDepartment of Cardiovascular Surgery, Kocaeli University School of Medicine, Kocaeli 41380, Turkey.
Tayfun SahinStructural Heart Interventions Unit, Department of Cardiology, Kocaeli University School of Medicine, Kocaeli 41380, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Myval is a balloon-expandable transcatheter heart valve (THV) developed by Meril Life Sciences Pvt. Ltd. (Vapi, Gujarat, India) that has an innovative operator-friendly design that aids in improving deliverability and features precise deployment. Various clinical studies demonstrate its effectiveness and safety, making it a promising choice in valvular interventions. Myval has been successfully utilized as a transcatheter aortic valve implantation (TAVI) device in cases with conduction disturbances, bicuspid aortic valve anatomy, non-calcified aortic regurgitation, dysfunctional stenosed right ventricular outflow tract (RVOT) conduits, pulmonary valve replacement, mitral valve replacement, and valve-in-valve and valve-in-ring implantation procedures. Myval's diverse sizes are also of key importance in complex cases of large annuli and complex anatomy. Further long-term studies are needed to consolidate these results. Its introduction signifies a significant advancement in cardiology, aiming to enhance patient outcomes and quality of life. In the present review, we provide an update on new-generation Myval THV series and review the available clinical data published to date with an emphasis on diverse use in specific clinical scenarios.

Indexed as

Myvalsafetytranscatheter aortic valve implantationtranscatheter heart valvevalve-in-valve implantation

Identifiers

PMID39598000
PMCPMC11594825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.